Russell Investments Group Ltd. grew its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 61.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 569,749 shares of the real estate investment trust's stock after acquiring an additional 217,500 shares during the period. Russell Investments Group Ltd. owned 0.24% of Sabra Healthcare REIT worth $9,954,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Allspring Global Investments Holdings LLC bought a new position in shares of Sabra Healthcare REIT in the first quarter valued at approximately $298,000. New York State Teachers Retirement System raised its stake in shares of Sabra Healthcare REIT by 12.1% in the first quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock valued at $5,619,000 after acquiring an additional 34,591 shares during the last quarter. M&T Bank Corp raised its stake in shares of Sabra Healthcare REIT by 2.1% in the first quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock valued at $905,000 after acquiring an additional 1,059 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in shares of Sabra Healthcare REIT by 4.7% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock valued at $331,000 after acquiring an additional 853 shares during the last quarter. Finally, Oppenheimer & Co. Inc. bought a new position in shares of Sabra Healthcare REIT in the first quarter valued at approximately $578,000. Institutional investors own 99.40% of the company's stock.
Sabra Healthcare REIT Trading Up 0.8%
SBRA traded up $0.16 during trading on Thursday, reaching $19.62. 1,952,554 shares of the company's stock were exchanged, compared to its average volume of 2,682,288. The company's fifty day moving average price is $18.42 and its 200-day moving average price is $17.67. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The firm has a market capitalization of $4.70 billion, a PE ratio of 25.82, a P/E/G ratio of 1.55 and a beta of 0.86.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. During the same quarter in the previous year, the business earned $0.36 EPS. The business's quarterly revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's payout ratio is currently 157.89%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently issued reports on SBRA shares. Scotiabank lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. JMP Securities boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $20.00.
Read Our Latest Stock Report on Sabra Healthcare REIT
About Sabra Healthcare REIT
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access